Chang Liu; Hairui Wang; Yixin Gu; Guilan Zhou; Xiaoli Chen; Xin Zhang; Jianzhong Zhang; Zhujun Shao; Maojun Zhang; Chang Liu; Hairui Wang; Yixin Gu; Guilan Zhou; Xiaoli Chen; Xin Zhang; Jianzhong Zhang; Zhujun Shao; Maojun Zhang

doi:10.46234/ccdcw2025.140

[1]

Audu BJ, Norval S, Bruno L, Meenakshi R, Marion M, Forbes KJ. Genomic diversity and antimicrobial resistance of Campylobacter spp. from humans and livestock in Nigeria. J Biomed Sci 2022;29(1):7. https://doi.org/10.1186/s12929-022-00786-2.

[2]

Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Davies R, et al. Update and review of control options for Campylobacter in broilers at primary production. EFSA J 2020;18(4):e06090. https://doi.org/10.2903/j.efsa.2020.6090.

[3]

Facciolà A, Riso R, Avventuroso E, Visalli G, Delia SA, Laganà P. Campylobacter: from microbiology to prevention. J Prev Med Hyg 2017;58(2):E79-92. https://pubmed.ncbi.nlm.nih.gov/28900347/.

[4]

Li Y, Zhou GL, Gao P, Gu YX, Wang HR, Zhang S, et al. Gastroenteritis outbreak caused by Campylobacter jejuni - Beijing, China, August, 2019. China CDC Wkly 2020;2(23):422 − 5. https://doi.org/10.46234/ccdcw2020.108.

[5]

Letunic I, Bork P. Interactive Tree of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021;49(W1):W293 − 6. https://doi.org/10.1093/nar/gkab301.

[6]

Liu F, Lee SA, Xue J, Riordan SM, Zhang L. Global epidemiology of campylobacteriosis and the impact of COVID-19. Front Cell Infect Microbiol 2022;12:979055. https://doi.org/10.3389/fcimb.2022.979055.

[7]

Shen ZQ, Wang Y, Zhang QJ, Shen JZ. Antimicrobial resistance in Campylobacter spp. Microbiol Spectr 2018;6(2). http://dx.doi.org/10.1128/microbiolspec.ARBA-0013-2017.

[8]

Li XF, Xu XX, Chen XY, Li YL, Guo JL, Gao J, et al. Prevalence and genetic characterization of Campylobacter from clinical poultry cases in China. Microbiol Spectr 2023;11(6):e0079723. https://doi.org/10.1128/spectrum.00797-23.

[9]

Zhang PH, Zhang XA, Liu YZ, Cui QP, Qin XX, Niu YL, et al. Genomic insights into the increased occurrence of Campylobacteriosis caused by antimicrobial-resistant Campylobacter coli. mBio 2022;13(6):e0283522. https://doi.org/10.1128/mbio.02835-22.

[10]

Van Vliet AHM, Thakur S, Prada JM, Mehat JW, La Ragione RM. Genomic screening of antimicrobial resistance markers in UK and US Campylobacter isolates highlights stability of resistance over an 18-year period. Antimicrob Agents Chemother 2022;66(5):e0168721. https://doi.org/10.1128/aac.01687-21.

[11]

Tang B, Wang Y, Luo Y, Zheng X, Qin XX, Yang H, et al. Coexistence of optrA and fexA in Campylobacter. mSphere 2021;6(3):e00125 − 21. https://doi.org/10.1128/mSphere.00125-21.

[12]

Tikhomirova A, McNabb ER, Petterlin L, Bellamy GL, Lin KH, Santoso CA, et al. Campylobacter jejuni virulence factors: update on emerging issues and trends. J Biomed Sci. 2024;31(1):45. https://doi.org/10.1186/s12929-024-01033-6.

[13]

Lopes BS, Strachan NJC, Ramjee M, Thomson A, MacRae M, Shaw S, et al. Nationwide stepwise emergence and evolution of multidrug-resistant Campylobacter jejuni sequence type 5136, United Kingdom. Emerg Infect Dis 2019;25(7):1320 − 9. https://doi.org/10.3201/eid2507.181572.